Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03528512Phase 4Terminated
A Phase 4 trial of ketamine in laceration, sponsored by Corewell Health. Started Sep 2018; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03528512.